B & L Biotech USA Inc.

B & L Biotech USA Inc., a minority-owned, self-certified small disadvantaged business and Asian-Pacific American-owned manufacturer headquartered in Fairfax, Virginia, supplies dental and surgical instruments, needles, condensers, gutta percha materials, and related medical consumables to the federal government as a prime contractor exclusively through a single-award indefinite delivery contract with the Defense Logistics Agency Troop Support Medical.

B & L Biotech operates entirely within one customer relationship and one parent vehicle. The vendor holds a $999,999,999 single-award Indefinite Delivery Contract (SPE2DE23D0028) with DLA Troop Support Medical, awarded June 5, 2023, running through June 4, 2028. This vehicle anchors 205 task orders valued at $91 thousand in combined potential value. The vendor also holds two legacy IDCs under the same contracting office — SPE2DE18D0008 with 446 task orders ($225 thousand combined potential) and SPM2DE13D7468 with 234 task orders ($116 thousand combined potential) — indicating sustained presence on DLA's dental and medical supplies procurement channel since at least 2013. All 888 awards in the source data fund Defense Logistics Agency Troop Support Medical programs, with no other federal customer represented.

Activity has moderated in recent years. The vendor generated 89 awards in 2022, peaked at 109 in 2023, then declined to 58 in 2024, 61 in 2025, and 31 in the first four months of 2026. Combined potential value across all 888 awards totals $1.01 billion, though obligated dollars remain minimal at $432 thousand — characteristic of the IDC model, where ceiling values are high and actual spend per delivery order is typically low. Individual task orders range from as little as $9 to $5,260 for specialized surgical instrument sets; the median order reflects consumable procurement (needles, gutta percha, condensers, tips) at hundreds of dollars per line. The vendor competes without set-aside designations, indicating full-and-open competition on DLA's medical supply schedule.

The vendor's product portfolio, grounded in task order descriptions across the source data, centers on precision dental and endodontic instruments and supplies. Representative items include 24mm and 26mm 25-gauge needles (recurring across hundreds of orders), gutta percha in soft, regular, and hard formulations, hand condensers and pluggers in multiple sizes, dental tips (BL 1A/E, 3A/E, 5A/E variants), surgical sets (JETXCHANGE Deluxe, JETIP Instrument Surgical Sets, microsurgery instrument sets), starter kits (ALPHA II and BETA variants in black), and specialty items such as vibra post tips, BLSEAL putty, ultrasonic tip valets, and dental mirrors. The vendor manufactures goods domestically and performs all work from its Fairfax, Virginia facility. Primary NAICS classification is 424450 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers), with dominant PSC coding under Laboratory Equipment and Supplies (831 awards) and Medical and Surgical Instruments, Equipment, and Supplies (57 awards).

No subcontracting footprint exists in the source data; B & L Biotech operates as a 100% prime contractor with no sub-awards recorded. The vendor's business model relies on a single-award IDC with a single customer — DLA Troop Support Medical — which creates concentration risk as the entire award portfolio depends on recompete performance on SPE2DE23D0028 when that contract approaches expiration in June 2028. The legacy vehicles (SPE2DE18D0008 and SPM2DE13D7468) appear to have ceased new task-order activity, suggesting consolidation of procurement onto the newer 2023 vehicle.